Add BrightSurf on Google Email

Search results for “Urology”

1,000+ results for "Urology"

UCLA study finds prostate cancer treatments impact on quality of life

A UCLA study found that three common prostate cancer treatments affect men's lives in different ways, with varying degrees of erectile dysfunction and urinary symptoms. The study tracked 580 men for five years and used a web-based data collection system to gather accurate information.

SourceUniversity of California - Los Angeles·JournalCancer·DateApr 23, 2007

Scientists find one reason why bladder cancer hits more men

Researchers found that the androgen receptor plays a key role in bladder cancer development, which explains why it affects men more than women. The discovery opens doors to new treatment options and may help doctors predict tumor recurrence.

SourceUniversity of Rochester Medical Center·JournalJNCI Journal of the National Cancer Institute·DateApr 20, 2007
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Nutrients in certain vegetables may provide cancer-fighting benefit

Research suggests that phytochemicals in cruciferous vegetables, such as broccoli and watercress, can stop human prostate cancer cells from growing and inhibit the formation of blood vessels that feed tumors. This study provides promising preliminary evidence for the potential anti-cancer properties of these vegetables.

SourceUniversity of Pittsburgh Schools of the Health Sciences·DateApr 17, 2007

Low education predicts lower quality of life for prostate cancer patients

Men with lower educational levels experience a significant drop in quality of life after prostate cancer treatment compared to those with more education. The study controlled for various factors, including income and healthcare access, to show that low education alone is associated with lower quality of life.

SourceUniversity of California - San Francisco·JournalCancer·DateApr 12, 2007

PSA doubling predicts prostate cancer recurrence

A detectable PSA level is first indicator of recurrent prostate cancer after radical prostatectomy, with a doubling time of less than three months indicating imminent death from prostate cancer. Patients with longer doubling times are at significant risk for disease recurrence and cancer-specific death.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateApr 9, 2007
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

PneuStep -- MRI-safe motor makes robotic biopsies possible

Researchers at Johns Hopkins Medicine have developed a motor that can safely power remote-controlled robotic medical devices for cancer biopsies and therapies guided by magnetic resonance imaging. The motor, dubbed PneuStep, is made entirely out of plastics, ceramics, and rubber and is driven by light and air.

SourceJohns Hopkins Medicine·DateApr 6, 2007

Biopsy may underestimate prostate cancer in obese and overweight men

A study by Duke University Medical Center researchers found that obese and overweight men are more likely to have aggressive prostate cancer than biopsy results indicate. This discrepancy may lead to inadequate or inappropriate treatment, emphasizing the need for more accurate biopsies.

SourceDuke University Medical Center·JournalUrology·DateMar 27, 2007

Magnetic system could be key to surgery without scars

Researchers at UT Southwestern Medical Center have developed a Magnetic Anchoring and Guidance System that uses magnets to attract and manipulate laparoscopic surgical tools. This new technique allows for magnetically maneuvering laparoscopic instruments inserted into the abdominal cavity through the bellybutton or throat.

SourceUT Southwestern Medical Center·JournalAnnals of Surgery·DateMar 26, 2007

Sutent achieves first line EAU approval for kidney cancer

The European Association of Urology (EAU) has recommended Sutent as a first-line treatment for patients with metastatic renal cell carcinoma. Clinical trials have shown that Sutent improves progression-free survival by more than doubling the median PFS compared to interferon-alpha. The new guidelines also highlight Sutent's higher obje...

SourceReynolds-MacKenzie·JournalEuropean Urology·DateMar 22, 2007
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

Hot tubs hurt fertility, UCSF study shows

A new study published in International Braz J Urol found that exposure to hot baths or hot tubs can lead to male infertility. However, the effects can be reversible if the practice is discontinued for at least three months. The study showed a significant increase in sperm motility among responders, with a mean increase of 491 percent a...

SourceUniversity of California - San Francisco·JournalInternational braz j urol·DateMar 2, 2007

Reactions to 'false-positive' prostate cancer screenings assessed

Men who receive false-positive prostate cancer results experience heightened anxiety about their risk of developing the disease and report issues with sexual function. The study emphasizes the importance of discussing the pros and cons of screening with patients to minimize adverse effects on quality of life.

SourceUniversity of Iowa·JournalUrology·DateMar 2, 2007

VA researcher finds way to identify which men need a second biopsy

A VA researcher has developed a method to identify men at risk for high-grade prostate cancer, reducing the need for unnecessary biopsies. The study found that a high PSA adjusted for prostate size and Gleason scores above 7 indicate a higher risk of life-threatening prostate cancer.

SourceOregon Health & Science University·DateFeb 22, 2007

Severe form of 'enlarged prostate' disease discovered

Scientists have identified a severe form of benign prostatic hyperplasia (BPH) tied to a gene called JM-27. A blood test detects high levels of this protein, indicating more severe symptoms. This discovery could lead to earlier diagnosis and targeted treatment for bladder-related complications.

SourceJohns Hopkins Medicine·JournalThe Journal of Urology·DateFeb 5, 2007
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

New biomarker test could predict outcome for bladder cancer patients

Researchers at UT Southwestern Medical Center have found a new biomarker test that can predict the recurrence of bladder cancer in patients. The test uses molecular biomarkers to identify patients who are more likely to experience cancer recurrence, allowing for personalized treatment options.

SourceUT Southwestern Medical Center·JournalThe Lancet Oncology·DateFeb 1, 2007

Synthetic cannabinoid may aid fertility in smokers

A study at the University at Buffalo found that synthetic cannabinoid AM-1346 can improve fertility in male smokers with poor semen quality, doubling fertilizing capacity. Researchers believe a communication imbalance between cannabinoid and cholinergic receptor systems may be responsible for nicotine-induced infertility.

SourceUniversity at Buffalo·DateDec 1, 2006
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

African-Americans with prostate cancer more likely to have family history of prostate, breast cancer

Research from the Flint Men's Health Study found that African-American men with prostate cancer were more likely to report a family history of both diseases among siblings. This increased risk was particularly notable for having a brother diagnosed with prostate cancer and a sister diagnosed with breast cancer, highlighting the importa...

SourceMichigan Medicine - University of Michigan·JournalUrology·DateDec 1, 2006

Gene therapy for erectile dysfunction shows promise in clinical trial

A clinical trial of gene transfer therapy for erectile dysfunction found significant and sustained improvements in patients who received a transfer gene called hMaxi-K. The therapy works by creating additional potassium channels in smooth muscle cells, relaxing the muscle and allowing blood flow required for an erection.

SourceAlbert Einstein College of Medicine·JournalHuman Gene Therapy·DateDec 1, 2006

Octogenarians are not too old for cancer surgery

Researchers found that a radical prostatectomy can be a viable option for select octogenarian patients with localized prostate cancer. The 10-year survival rate was similar to that observed in healthy patients 60-79 years old undergoing a radical prostatectomy.

SourceMayo Clinic·JournalUrology·DateNov 27, 2006
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

'Muscle' protein drives prostate cancer

Researchers at Johns Hopkins Kimmel Cancer Center found overproduction of myosin VI in prostate tumor cells and precancerous lesions. Silencing myosin VI in lab studies reduced cell invasion, suggesting its critical role in starting and maintaining malignant properties of most human prostate cancers.

SourceJohns Hopkins Medicine·JournalAmerican Journal Of Pathology·DateNov 8, 2006

Newer approach urged in screening for aggressive prostate cancer

Researchers found that a man's PSA velocity, or rate of increase in PSA levels, can accurately predict tumor aggression and danger. Men with lower PSA velocity have a 92% chance of not dying from prostate cancer within 25 years.

SourceJohns Hopkins Medicine·JournalJNCI Journal of the National Cancer Institute·DateOct 31, 2006
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

USC researchers discover breast cancer stem cells in bone marrow

Researchers found that nearly all tumor cells in the bone marrow of early-stage breast cancer patients have a putative breast cancer stem cell phenotype, increasing the risk of disease progression. This study provides evidence that these stem cells may be responsible for metastases and has significant implications for cancer treatment.

SourceUniversity of Southern California·JournalClinical Cancer Research·DateOct 5, 2006

Many urinary stones can be treated without surgery

Researchers analyzed nine trials involving 693 patients and found that treatment with calcium-channel blockers or alpha blockers increased the chances of passing urinary stones by 65%, making these medications an effective alternative to surgery.

SourceMichigan Medicine - University of Michigan·JournalThe Lancet·DateSep 29, 2006

Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later

A study by Memorial Sloan Kettering Cancer Center found that high-dose intensity modulated radiation therapy (IMRT) achieved a 89% disease-free rate for patients with prostate cancer after an average of 8 years. The treatment also showed improved quality of life by reducing side effects and maintaining urinary continence.

SourceMemorial Sloan Kettering Cancer Center·JournalThe Journal of Urology·DateSep 27, 2006

More kidney cancer is detected and treated early, yet death rate rises

A University of Michigan Health System study found that while more small kidney tumors are being detected and treated, the death rate from kidney cancer is not decreasing. The researchers suggest re-examining treatment strategies for patients with small renal masses, as surgery may not be the best option for everyone.

SourceMichigan Medicine - University of Michigan·JournalJNCI Journal of the National Cancer Institute·DateSep 19, 2006
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Study drug holds promise as alternative to castration for early prostate cancers

Researchers found a daily dose of 150mg bicalutamide reduced disease progression risk by 44% and overall death risk by 35% compared to radiotherapy alone. This non-castration-based therapy shows similar survival rates, potentially improving quality of life for patients unwilling to undergo castration.

SourceMedical College of Wisconsin·JournalJournal of Cancer Research and Clinical Oncology·DateAug 22, 2006

U-M study finds some prostate cancer patients potentially overtreated

A new study found that over half of men with lower-risk prostate cancer received aggressive treatment, despite active surveillance being a viable option. Men under 55 were more likely to receive surgery, while those aged 70-74 were more likely to receive radiation.

SourceMichigan Medicine - University of Michigan·JournalJNCI Journal of the National Cancer Institute·DateAug 15, 2006
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Heat therapy for cancer may be key to 'Lance Armstrong Effect'

Scientists at Johns Hopkins believe that heat therapy can selectively target and kill cancer cells by disrupting their nuclear protein scaffolding. Preliminary research suggests that this approach could be effective in treating solid tumors, with the goal of improving cure rates.

SourceJohns Hopkins Medicine·JournalJAMA·DateJul 25, 2006

UCLA researchers transform stem cells found in human fat into smooth muscle cells

Researchers at UCLA have successfully transformed adult stem cells from human adipose tissue into functional smooth muscle cells, which can help regenerate damaged organs like the intestine, bladder, and arteries. The study's findings offer a promising alternative to using patient's own tissue for organ regeneration without anti-reject...

SourceUniversity of California - Los Angeles·JournalProceedings of the National Academy of Sciences·DateJul 24, 2006
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Two-thirds of patients say erection drug didn't work for them

A large-scale study found that two-thirds of patients stopped using Uprima due to ineffectiveness, with 70% of family doctors agreeing. The study analyzed data from 11,185 patients and showed that the most common adverse reactions were headache and nausea.

SourceBlackwell Publishing Ltd.·JournalBJU International·DateJul 10, 2006

Study shows prostate cancer vaccine linked to longer survival

A study shows that a prostate cancer vaccine, sipuleucel-T, can increase survival by up to four-and-a-half months and provide a greater than three-fold increase in survival at 36 months compared to patients in the placebo group. The vaccine was well-tolerated with mild adverse effects.

SourceUniversity of California - San Francisco·JournalJournal of Clinical Oncology·DateJun 29, 2006
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Smoking and obesity may increase the risk of erectile dysfunction

A large-scale study found that smoking and obesity are strongly associated with a greater risk of erectile dysfunction (ED), while regular physical activity lowers the risk. Regular exercise was found to reduce ED risk by 2.5 times, emphasizing the importance of adopting a healthier lifestyle.

SourceHarvard T.H. Chan School of Public Health·JournalThe Journal of Urology·DateJun 27, 2006

U of M study examines kidney stone prevention in astronauts

A University of Minnesota study found that exercise in a machine simulating gravity can reduce the risk of developing kidney stones in astronauts. Researchers used identical twins to test the effect of exercise on urinary calcium levels, and the results suggest a potential solution for preventing this painful condition.

SourceUniversity of Minnesota·JournalThe Journal of Urology·DateJun 27, 2006

New test detects prostate cancer spread at the earliest time

A new test has been developed to detect prostate cancer spread in lymph nodes at an earlier stage, which may lead to better treatments and improved patient outcomes. The test was found to be more sensitive than existing methods and associated with increased recurrence and decreased survival rates.

SourceUniversity of Southern California·JournalJournal of Clinical Oncology·DateJun 20, 2006

Race plays a key role in prostate cancer survival rates

A study comparing Japanese American and white male patients who received hormone treatment for prostate cancer found that the former had a significantly higher five-year overall survival rate of 66% compared to 42%. The result was not affected by cancer stage or PSA levels, suggesting genetic and lifestyle factors may play a role.

SourceBlackwell Publishing Ltd.·JournalBJU International·DateJun 12, 2006
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Early estrogen exposure leads to later prostate cancer risk

A study found that early exposure to estrogen or BPA increases the risk of precancerous lesions in the prostate. Researchers discovered that this leads to epigenetic reprogramming, altering gene expression patterns that promote prostate disease with aging.

SourceUniversity of Illinois Chicago·JournalCancer Research·DateJun 1, 2006

ST. John's Wort relieves bladder pain in animal models

Researchers found that St. John's Wort increased bladder contraction intervals in rats with bladder inflammation, reducing bladder hyperactivity and associated pain. The study suggests that the herbal supplement may be a viable treatment option for women suffering from interstitial cystitis, affecting 700,000 Americans.

SourceUniversity of Pittsburgh Medical Center·DateMay 23, 2006

Botox: Its not just for wrinkles anymore

Researchers found Botox injections to improve urinary tract symptoms and quality of life in men with enlarged prostates. The treatment reduced prostate size through apoptosis, improving urine flow and decreasing residual urine.

SourceUniversity of Pittsburgh Medical Center·DateMay 23, 2006
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Marijuana-derived drug suppresses bladder pain in animal models

A new marijuana-derived drug, IP 751, has shown significant promise in suppressing bladder overactivity and alleviating painful symptoms in animal models of interstitial cystitis. Researchers at the University of Pittsburgh School of Medicine developed a liposome-based delivery system to overcome the hydrophobic properties of the drug.

SourceUniversity of Pittsburgh Medical Center·DateMay 21, 2006